|
INTS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.239330E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.203100E-04 |
| Normal-vs-Stage2 |
5.56659999999543E-05 |
| Normal-vs-Stage3 |
3.86159999999913E-05 |
| Normal-vs-Stage4 |
2.013100E-04 |
| Stage1-vs-Stage2 |
1.374190E-01 |
| Stage1-vs-Stage3 |
6.472200E-02 |
| Stage1-vs-Stage4 |
4.424000E-01 |
| Stage2-vs-Stage3 |
9.124400E-01 |
| Stage2-vs-Stage4 |
5.496400E-01 |
| Stage3-vs-Stage4 |
5.636200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99790000000278E-05 |
| Normal-vs-AfricanAmerican |
2.407600E-02 |
| Normal-vs-Asian |
5.165200E-04 |
| Caucasian-vs-AfricanAmerican |
2.742000E-01 |
| Caucasian-vs-Asian |
6.612800E-01 |
| AfricanAmerican-vs-Asian |
4.291600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44119999999182E-05 |
| Normal-vs-Female |
2.578000E-04 |
| Male-vs-Female |
4.902200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.815500E-04 |
| Normal-vs-Age(41-60Yrs) |
5.69790000000125E-05 |
| Normal-vs-Age(61-80Yrs) |
1.003970E-04 |
| Normal-vs-Age(81-100Yrs) |
3.156100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.831800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.019800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.272610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.051200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.901800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.256400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.020800E-01 |
| Classical-VS-Follicular |
9.188000E-02 |
| Classical-VS-Other |
4.510200E-01 |
| Classical-VS-Normal |
4.635800E-04 |
| Tall-VS-Follicular |
7.714200E-01 |
| Tall-VS-Other |
7.032400E-01 |
| Tall-VS-Normal |
2.174800E-04 |
| Follicular-VS-Other |
8.689000E-01 |
| Follicular-VS-Normal |
8.15020000000111E-05 |
| Other-VS-Normal |
1.216050E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.65810000000355E-05 |
| Normal-vs-N1 |
1.616550E-04 |
| N0-vs-N1 |
6.705000E-01 |
|
|
